Analytical Data
-
基因名
DDX1
- Application
-
别名
(DEAD box protein 1)(DEAD box protein retinoblastoma)(DBP-RB)
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q92499
-
表达区间
1-740aa
-
分子量
89.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DDX1, a member of the DEAD-box RNA helicase family, plays a crucial role in various cellular processes, including RNA metabolism, splicing, and translation. Its significance has been underscored in several studies linking DDX1 to cancer biology, viral infections, and immune responses. Dysregulation of DDX1 expression has been associated with tumorigenesis, highlighting its potential as a biomarker for cancer prognosis. Recent advancements in recombinant protein technology have enabled the production of DDX1 in significant quantities, facilitating in-depth studies on its structure-function relationship and interaction with RNA substrates. Furthermore, understanding the mechanistic roles of DDX1 could provide insights into therapeutic strategies targeting RNA processing pathways. Researchers are now focusing on characterizing the biochemical properties of recombinant DDX1, including its helicase activity and affinity for various RNA sequences, which may lead to novel approaches in cancer treatment and antiviral therapies. The development of DDX1 as a recombinant protein not only opens avenues for basic research but also enhances our understanding of its regulatory mechanisms, reinforcing its importance in cellular homeostasis and disease contexts. Overall, the study of DDX1 as a recombinant protein is pivotal for elucidating its broader implications in molecular biology and therapeutic applications.
